Zhijun Song | Antimicrobial | Best Researcher Award

Posted on by Infectious

Best Researcher Award

Zhijun Song
Ningxia Medical University
Zhijun Song
Affiliation Ningxia Medical University
Country China
Scopus ID 57194452080
Documents 25
Citations 235
h-index 10
Subject Area Antimicrobial
Event International Research Awards on Infectious Diseases
ORCID 0009-0000-4972-2344

The Best Researcher Award recognizes scholarly excellence, scientific productivity, and sustained contributions to advancing knowledge in specialized research domains. Zhijun Song of Ningxia Medical University has established a research profile in antimicrobial and infectious disease investigations, contributing to scientific understanding through peer-reviewed publications and collaborative academic activities. His documented research output, citation performance, and subject expertise provide evidence of meaningful engagement within contemporary biomedical research environments.[1]

Abstract

This article presents an academic overview of Zhijun Song and his contributions to antimicrobial and infectious disease research. Affiliated with Ningxia Medical University, Song has developed a publication record that reflects engagement with contemporary biomedical challenges, particularly those associated with microbial pathogens, antimicrobial resistance, and disease management. His scholarly activities demonstrate a commitment to evidence-based research, interdisciplinary collaboration, and scientific dissemination. Citation metrics and publication performance indicate measurable influence within his field. These achievements support recognition through the Best Researcher Award presented at the International Research Awards on Infectious Diseases, highlighting contributions that advance scientific understanding and support future innovations in public health and infectious disease research.[1][2]

Keywords

Antimicrobial Research, Infectious Diseases, Biomedical Science, Microbial Pathogens, Public Health, Scientific Publications, Research Excellence, Citation Impact, Academic Recognition, Best Researcher Award.

Introduction

Infectious diseases remain a major global health concern, requiring continuous scientific investigation and innovation. Researchers working in antimicrobial sciences contribute significantly to understanding disease mechanisms and therapeutic approaches. Zhijun Song’s academic activities align with these objectives through research efforts focused on advancing biomedical knowledge and supporting evidence-based healthcare developments.[2]

Research Profile

Zhijun Song is affiliated with Ningxia Medical University in China and has established a documented research presence in antimicrobial studies. His Scopus profile records 25 scholarly documents, 235 citations, and an h-index of 10, reflecting active participation in scientific publishing and knowledge dissemination within infectious disease research communities.[1]

Research Contributions

Research contributions attributed to Song include investigations relevant to antimicrobial science, pathogen-related studies, and healthcare-oriented biomedical research. His work supports improved understanding of infectious disease challenges and contributes to the broader scientific dialogue addressing prevention, diagnosis, and treatment strategies in modern healthcare systems.[2]

Publications

The researcher’s publication portfolio demonstrates continued engagement with peer-reviewed scientific communication. Published works contribute to antimicrobial and infectious disease literature while facilitating scholarly exchange among researchers, clinicians, and healthcare professionals. These outputs collectively support the dissemination of research findings and advancement of evidence-based scientific practice.[1]

Research Impact

Citation indicators provide one measure of scholarly influence within academic communities. With over two hundred citations, Song’s research has been referenced by fellow investigators, indicating relevance and utility within ongoing scientific discussions. Such engagement reflects the value of his contributions to infectious disease and antimicrobial research.[1]

Award Suitability

The Best Researcher Award emphasizes originality, productivity, scholarly impact, and professional commitment. Based on documented publication activity, citation performance, and specialized expertise in antimicrobial research, Zhijun Song demonstrates characteristics commonly associated with academic recognition programs focused on advancing infectious disease research and scientific excellence.[3]

Conclusion

Zhijun Song’s scholarly record illustrates sustained participation in antimicrobial and infectious disease research. Through publications, citations, and academic engagement, he has contributed to scientific understanding within his field. These achievements support consideration for recognition through the Best Researcher Award at the International Research Awards on Infectious Diseases.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Zhijun Song, Author ID 57194452080. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57194452080
  2. ORCID. (n.d.). ORCID profile record for Zhijun Song.
    https://orcid.org/0009-0000-4972-2344
  3. Fan, W., Wang, X., & Song, Z. (n.d.). Targeted discovery of bioactive secondary metabolites from an endophytic fungus Phomopsis sp. LGT-5 by OSMAC-activated and HPLC-UV-guided isolation.
    https://www.sciencedirect.com/science/article/abs/pii/S0305197826000530

Janet Nale | Microbial Pathogenesis | Innovative Research Award

Posted on by Infectious

Innovative Research Award

Janet Nale
Affiliation Scotland’s Rural College
Country United Kingdom
Scopus ID 55247908300
Documents 25
Citations 821
h-index 13
Subject Area Microbial Pathogenesis
Event International Research Awards on Infectious Diseases
ORCID
0000-0003-0501-7402
Janet Nale
Scotland’s Rural College, United Kingdom

The Innovative Research Award recognizes notable scholarly contributions in the field of microbial pathogenesis and infectious disease research. Janet Nale, affiliated with Scotland’s Rural College in the United Kingdom, has established a recognized academic profile through interdisciplinary research focused on microbial interactions, bacteriophage applications, and pathogenic mechanisms associated with infectious diseases.[1] The researcher has contributed to peer-reviewed scientific literature indexed within major international databases and has demonstrated measurable research impact through citations and collaborative scientific output.[2]

Abstract

This academic profile summarizes the scholarly achievements and scientific contributions of Janet Nale within the discipline of microbial pathogenesis and infectious disease research. The profile highlights research productivity, citation metrics, peer-reviewed publications, and interdisciplinary investigations relevant to microbial interactions and bacteriophage-mediated therapeutic strategies.[2] The documented academic impact reflects sustained engagement in scientific inquiry associated with pathogen control, antimicrobial alternatives, and microbiological innovation within agricultural and biomedical contexts.[3]

Keywords

Microbial Pathogenesis, Infectious Diseases, Bacteriophage Therapy, Antimicrobial Resistance, Veterinary Microbiology, Pathogen Control, Scientific Innovation, Academic Research Impact

Introduction

Research concerning microbial pathogenesis remains a central component of global infectious disease investigations due to the increasing prevalence of antimicrobial resistance and emerging pathogenic threats.[4] Janet Nale has contributed to this field through research associated with bacteriophage biology, pathogen-host interactions, and microbial ecology. The academic contributions linked with Scotland’s Rural College demonstrate engagement in applied microbiological studies with relevance to both veterinary and public health domains.[5]

Research Profile

Janet Nale is associated with Scotland’s Rural College in the United Kingdom and maintains a documented scholarly presence within international indexing platforms including Scopus and ORCID.[1] The research profile includes 25 indexed documents, 821 citations, and an h-index of 13, reflecting measurable academic engagement and citation visibility within microbial sciences.[2]

Research Contributions

The research contributions associated with Janet Nale include studies on bacteriophage characterization, antimicrobial alternatives, and pathogen management strategies. Scientific investigations have explored bacteriophage-host interactions relevant to the control of infectious bacterial populations and the mitigation of antimicrobial resistance concerns.[7]

Publications

Selected publications attributed to Janet Nale include studies concerning bacteriophage applications, microbial pathogen analysis, and therapeutic microbiology. These publications have appeared in peer-reviewed scientific journals focused on microbiology, infectious diseases, and microbial pathogenesis.[7]

  1. Research involving bacteriophage-mediated control of pathogenic bacteria and antimicrobial-resistant organisms.[7]
  2. Studies examining microbiological interactions relevant to infectious disease transmission and prevention.[8]

Research Impact

The research impact of Janet Nale is reflected through citation metrics, indexed scholarly publications, and interdisciplinary collaborations documented within academic databases.[2] An h-index of 13 indicates a consistent level of citation engagement across multiple publications, while the citation count of 821 demonstrates the relevance of the researcher’s work within microbial pathogenesis and infectious disease studies.[1]

Award Suitability

The documented academic profile of Janet Nale demonstrates suitability for recognition within the International Research Awards on Infectious Diseases due to sustained scholarly activity, citation impact, and subject specialization in microbial pathogenesis.[3] The combination of indexed publications, interdisciplinary scientific collaborations, and contributions to bacteriophage research supports the significance of the researcher’s work within contemporary infectious disease studies.[7]

Conclusion

Janet Nale has developed an established academic profile through contributions to microbial pathogenesis and infectious disease research. The researcher’s publication record, citation metrics, and scientific investigations demonstrate engagement with contemporary microbiological challenges associated with pathogen control and antimicrobial resistance.[2] The overall scholarly profile reflects sustained scientific productivity and interdisciplinary research relevance suitable for academic recognition within international infectious disease award programs.

References

  1. Elsevier. (n.d.). Scopus author details: Janet Nale, Author ID 55247908300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55247908300
  2. ORCID. (n.d.). Janet Nale: ORCID researcher profile.
    https://orcid.org/0000-0003-0501-7402
  3. Nale, J. Y., Redgwell, T. A., Millard, A., & Clokie, M. R. J. (n.d.). Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.
    https://pubmed.ncbi.nlm.nih.gov/29438355/
  4. Nale, J. Y., Shan, J., Hickenbotham, P. T., Fawley, W. N., Wilcox, M. H., & Clokie, M. R. J. (n.d.). Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains.
    https://pubmed.ncbi.nlm.nih.gov/22624004/
  5. Nale, J. Y., Spencer, J., Hargreaves, K. R., Buckley, A. M., Trzepiński, P., & Douce, G. R. (n.d.). Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.
    https://pubmed.ncbi.nlm.nih.gov/26643348/

Carmen Hidalgo Tenorio | Antimicrobial | Women Researcher Award

Posted on by Infectious

Women Researcher Award

Carmen Hidalgo Tenorio
Virgen de las Nieves University Hospital
Researcher Information
Affiliation Virgen de las Nieves University Hospital
Country Spain
Scopus ID 6603351861
Documents 188
Citations 4121
h-index 30
Subject Area Antimicrobial
Event International Research Awards on Infectious Diseases

The Women Researcher Award recognizes the scholarly and scientific contributions of researchers who have demonstrated sustained academic engagement and professional impact within the field of infectious diseases and antimicrobial research. Carmen Hidalgo Tenorio, affiliated with Virgen de las Nieves University Hospital in Spain, has contributed to scientific investigations associated with infectious disease management, antimicrobial therapy, and related clinical research domains.[1] Her publication profile, citation record, and interdisciplinary collaborations reflect continued participation in evidence-based healthcare and biomedical research initiatives.[2]

Abstract

Carmen Hidalgo Tenorio has established a recognized academic profile through research activities connected to infectious diseases, antimicrobial management, and clinical healthcare investigations. Her scholarly output includes peer-reviewed publications, collaborative medical studies, and clinical analyses addressing therapeutic approaches and epidemiological considerations within infectious disease practice.[2] With an h-index of 30 and more than four thousand citations, her research record demonstrates measurable scientific visibility and influence within indexed academic literature.[1] The Women Researcher Award acknowledges these contributions as part of broader efforts to recognize excellence and leadership among women in biomedical and antimicrobial sciences.

Keywords

Women Researcher Award, Antimicrobial Research, Infectious Diseases, Clinical Microbiology, Academic Recognition, Biomedical Publications, Research Impact, Medical Research

Introduction

Recognition programs within biomedical sciences are designed to highlight sustained scientific productivity, interdisciplinary collaboration, and advancements that support healthcare development. The Women Researcher Award within the International Research Awards on Infectious Diseases emphasizes the importance of inclusive scientific leadership and acknowledges contributions made by women researchers in clinical and translational medicine.[2]

Carmen Hidalgo Tenorio has participated in research initiatives addressing infectious diseases and antimicrobial-related healthcare topics through clinical studies and scholarly dissemination. Her documented publication activity and citation metrics suggest continuing engagement in internationally indexed scientific communication platforms.[1] Such academic contributions are relevant within the context of modern infectious disease management and evidence-based medicine.

Research Profile

The research profile of Carmen Hidalgo Tenorio reflects activity in clinical infectious diseases and antimicrobial investigations associated with healthcare environments. Her affiliation with Virgen de las Nieves University Hospital has supported participation in medical research addressing therapeutic strategies, infectious disease outcomes, and patient-centered healthcare analysis.[2]

Her Scopus-indexed academic portfolio includes 188 documented publications with more than 4,000 citations, indicating consistent scholarly visibility across international databases.[1] Citation indicators such as the h-index provide measurable evidence of research dissemination and influence within scientific communities focused on infectious disease research and antimicrobial science.

Research Contributions

The scientific contributions associated with Carmen Hidalgo Tenorio encompass collaborative clinical investigations, peer-reviewed medical publications, and participation in antimicrobial and infectious disease-related studies. Her research activity has contributed to the broader scientific understanding of infectious disease treatment practices and healthcare outcomes.[2]

  • Participation in infectious disease and antimicrobial clinical research initiatives.
  • Contribution to peer-reviewed scientific publications indexed in international databases.
  • Engagement in interdisciplinary healthcare and therapeutic investigations.
  • Support for evidence-based medical practices through academic dissemination.
  • Collaboration with institutional and clinical research teams in biomedical sciences.

Publications

Selected scholarly publications and indexed research outputs associated with Carmen Hidalgo Tenorio demonstrate engagement in infectious disease and antimicrobial studies.[2]

  1. Clinical investigations related to infectious disease management and antimicrobial therapy.
  2. Collaborative hospital-based research addressing patient outcomes and therapeutic effectiveness.
  3. Peer-reviewed studies indexed within Scopus and related academic databases.
  4. Research dissemination through biomedical journals and international scientific communication platforms.

Research Impact

Research impact within biomedical science is commonly assessed using citation frequency, publication quality, collaborative engagement, and academic dissemination. Carmen Hidalgo Tenorio’s citation profile and publication metrics indicate continuing scientific relevance in infectious disease and antimicrobial research contexts.[1]

Her documented academic influence reflects contributions to ongoing discussions surrounding clinical infectious disease management and healthcare-related biomedical investigations. The measurable visibility of her publications within indexed databases further demonstrates the international accessibility and recognition of her scientific work.[2]

Award Suitability

The Women Researcher Award is intended to recognize researchers whose academic activities demonstrate scientific rigor, measurable research productivity, and meaningful contributions to infectious disease and antimicrobial sciences. Carmen Hidalgo Tenorio’s publication history, institutional affiliation, and citation performance collectively align with the evaluative considerations commonly associated with international academic recognition programs.[2]

Her involvement in peer-reviewed clinical investigations and evidence-based medical research reflects sustained participation in healthcare-oriented scientific advancement. Such characteristics contribute to her suitability for recognition within international research award initiatives focused on infectious diseases and antimicrobial innovation.

Conclusion

Carmen Hidalgo Tenorio represents an established academic contributor within the field of infectious diseases and antimicrobial research. Her indexed publications, citation performance, and institutional research activities demonstrate sustained scholarly engagement in biomedical science.[1] The Women Researcher Award recognizes these scientific contributions while supporting broader visibility for women researchers participating in healthcare and infectious disease advancement initiatives.

References

  1. Elsevier. (n.d.). Scopus author details: Carmen Hidalgo Tenorio, Author ID 6603351861. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6603351861
  2. ORCID. (n.d.). ORCID profile of Carmen Hidalgo Tenorio. ORCID Registry.
    https://orcid.org/0000-0002-6394-5728

Nominee | Subject Area | Award Category

Posted on by Infectious

Your Nomination Has Been Selected

Congratulations. Your nomination has been officially approved and selected.
Award profile publication, certification, and verification services
are enabled only after successful registration.

Important: This page is published for registration purposes only.
Public announcement and verification services will be activated after registration.

Free Services Included

  • Nomination acknowledgement
  • Expert review process
  • Published award winners announcement list –

    View list
  • A dedicated nominee details page for verification purposes –

    Sample page

Registration Benefits (Select as You Wish)

  • Profile publication –

    Sample
  • Certification and verification services –

    Sample
  • Printed certificate by post
  • Printed momento by post
  • Online e-certificate download (any time)
  • QR-code verified certificate linked to a public verification page
  • Media posts publication
  • Winners promotional video publication
  • Award event celebrations
  • Global award indexing


Register Here

Digital credentials are typically available within 2–3 working days after registration.
Printed certificates and mementos are dispatched within
30–45 days via secure international air post.

Xin Su | Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Xin Su | Infectious Diseases | Best Researcher Award

Attending Physician | Nanjing University | China

Professor Xin Su, M.D., Ph.D., is a distinguished clinical scientist and Chief Physician renowned for his pioneering contributions to respiratory and critical care medicine, with particular expertise in the study and management of severe pulmonary infections. Over a distinguished career spanning nearly three decades, he has demonstrated an exceptional ability to bridge clinical excellence with translational research innovation. His work focuses on the pathogenesis, diagnosis, and treatment of invasive pulmonary aspergillosis (IPA) in non-neutropenic patients, a challenging and underexplored domain of pulmonary medicine. As a leading investigator, Professor Su has spearheaded multicenter studies that have transformed the understanding of pulmonary fungal infections, combining rigorous clinical observation with the use of novel diagnostic technologies, including machine learning and metagenomic sequencing. His publications in high-impact journals such as The Lancet Infectious Diseases, Microbiology Spectrum, Frontiers in Cellular and Infection Microbiology, and Clinical Microbiology and Infection reflect a deep commitment to advancing evidence-based practices and diagnostic accuracy in the field. Through his groundbreaking studies, Professor Su has introduced innovative diagnostic models that integrate big data analytics with clinical biomarkers, offering more precise and timely identification of IPA and related fungal diseases. Beyond diagnostics, his investigations into host immune responses, interferon signaling, and biomarker development have opened new avenues for prognostic assessment and personalized treatment strategies. His leadership roles as a Chief Physician, Professor, and Doctoral Supervisor at Nanjing University-affiliated hospitals underscore his dual impact as both a clinician and academic mentor. Colleagues and collaborators recognize his unique ability to unite global expertise, as evidenced by his participation in international research consortia addressing fungal infections and severe pneumonia outcomes. His scholarly rigor, coupled with his mentorship of young clinicians and researchers, has significantly enriched the field of respiratory and infectious disease research. While Professor Su’s scientific achievements are substantial, he continues to identify strategic growth areas that align with the evolving challenges of respiratory medicine. Expanding the clinical utility of machine learning-based diagnostic platforms, validating novel biomarkers in diverse patient populations, and enhancing global collaborative networks remain key objectives. Moreover, strengthening translational pathways that connect molecular diagnostics to frontline patient care is an ongoing priority, ensuring that innovations in the laboratory translate into improved clinical outcomes. Looking ahead, Professor Su’s future research aims to deepen the mechanistic understanding of host-pathogen interactions in fungal and viral co-infections, refine AI-driven diagnostic algorithms for pulmonary infections, and integrate multi-omics data into clinical decision-making frameworks. His vision is to establish an internationally recognized precision-medicine model for diagnosing and managing severe respiratory infections, ultimately contributing to reduced mortality, optimized therapeutic strategies, and global health resilience in the era of emerging respiratory pathogens. He has 2677 citations from 128 documents with an h-index of 28.

Profiles: Scopus | ORCID

Publications

1. Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis. (2025). Microbiology Spectrum.

2. Rapid and accurate diagnosis of severe pneumonia: Similarities and differences between severe community-acquired pneumonia and hospital-acquired pneumonia/ventilator-associated pneumonia. (2025). Chinese Journal of Tuberculosis and Respiratory Diseases.

3. Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: A multicenter cohort study. (2025). Microbiology Spectrum.

4. Expert consensus on cancer treatment-related lung injury. (2025). Journal of Thoracic Disease.

5. Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients. (2025). Microbiology Spectrum.

Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Yvonne Hernandez-Kapila | Infectious Diseases | Best Researcher Award 

Professor | UCLA | United States

Dr. Yvonne L. Hernandez-Kapila is a distinguished clinician-scientist, academic leader, and global research contributor recognized for her transformative work in oral biology, periodontology, and cancer biology. As Professor and Associate Dean for Research at the UCLA School of Dentistry and the Felix and Mildred Yip Endowed Chair in Dentistry, her research has significantly advanced understanding of the molecular and cellular mechanisms underlying periodontal disease, oral cancer, and host-microbiome interactions. Her laboratory’s pioneering investigations into the oral-gut-brain axis, bacteriocin therapeutics, and oral virome have shaped new paradigms in microbial pathogenesis, inflammation, and regenerative oral health. A prolific author with more than a hundred peer-reviewed publications in leading journals such as NPJ Biofilms and Microbiomes, Journal of Biological Chemistry, PLOS Pathogens, and Cell Death and Differentiation, Dr. Kapila’s work bridges fundamental discovery with translational innovation. She has served as principal investigator on multiple NIH-funded projects, including major initiatives exploring host–bacterial dynamics and microbiome modulation in oral and systemic disease contexts. Her editorial leadership extends across several international journals and major textbooks, including Periodontology 2000 and Newman and Carranza’s Clinical Periodontology, where she continues to shape scholarly discourse in the field. Dr. Kapila has received numerous prestigious honors recognizing her scientific excellence, mentorship, and contributions to dental research, including awards from the American Dental Association, the American Academy of Periodontology, and the American Association for Dental Research. A dedicated mentor, she has guided over a hundred trainees and junior faculty toward successful academic and research careers worldwide, championing inclusivity, rigorous scientific methodology, and leadership development. Through her interdisciplinary collaborations and global initiatives, Dr. Kapila continues to influence the future of oral health sciences, biomolecular therapeutics, and translational medicine, establishing herself as a leading voice in advancing oral-systemic health research on an international scale. She has 8347 citations from 146 documents with an h-index of 47.

Profiles: Scopus | ORCID

Publications

1. B. lactis HN019 modulates periapical inflammation and enhances cementum repair by increasing CEMP-1 expression in an animal model. (2025). Archives of Oral Biology.

2. The antimicrobial peptide nisin promotes host cell survival during SARS-CoV-2 infection. (2025). Virology Journal.

3. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis. (2024). NPJ Biofilms and Microbiomes.

4. Biological biomarkers of oral cancer. (2025). [Journal name not specified].

5. Nisin, a probiotic bacteriocin, modulates the inflammatory and microbiome changes in female reproductive organs mediated by polymicrobial periodontal infection. (2024). Microorganisms.

Ahmed Ahmed Olaitan | Global Health and Infectious Disease Burden | Young Scientist Award

Posted on by Infectious

Mr. Ahmed Ahmed Olaitan | Global Health and Infectious Disease Burden | Young Scientist Award

PhD Scholar  |  Universiti Sultan Zainal Abidin  |  Nigeria

Mr. Ahmed Ahmed Olaitan is an emerging academic and research scholar whose work bridges sociology, environmental studies, and sustainable development. His professional experience spans research, teaching, and community leadership, with active roles as a Lecturer at the Federal College of Forest Resources Management in Ishiagu, Nigeria, and a Research Fellow at the Forestry Research Institute of Nigeria. His research contributions focus on traditional healthcare practices, indigenous community development, social and environmental sustainability, and the socio-economic dimensions of forestry and agroforestry. He has co-authored multiple peer-reviewed journal articles that explore the intersections of social systems, environmental conservation, and cultural knowledge transmission. His scholarly efforts extend to participation in national and international conferences, where he has presented research on environmental management, indigenous education, and climate change awareness. Ahmed’s research skills encompass qualitative and quantitative methodologies, data analysis using PLS-SEM, SPSS, NVivo, and Excel, and the development of community-based research frameworks that support sustainable livelihoods. His academic excellence has been recognized with honors, including the Graduate on Time Award from Universiti Sultan Zainal Abidin, highlighting his dedication to timely and impactful scholarship. He has also served in leadership capacities such as Treasurer of the International Student Society at Universiti Sultan Zainal Abidin and Principal of Sheikh Ahmad Islamic School in Ilorin, Nigeria, where he promotes education and community empowerment. His work demonstrates a strong commitment to social innovation, research excellence, and practical approaches to achieving sustainable development goals. With a growing academic profile and a collaborative approach to interdisciplinary inquiry, Ahmed continues to contribute significantly to both scholarly research and societal advancement. He has achieved 22 Citations, 9 Documents, 3 h-index .

Profiles:  Google Scholar | ORCID | Scopus 

Featured Publications

  1. GO Victory, Oyewole, A. L., & Olaitan, A. A. (2022). Climate-smart agricultural practices at Oyo State, Nigeria. South Asian Journal of Social Review, 1(1), 1–7.
    Citations: 45

  2. Tokede, A. M., Banjo, A. A., Ahmad, A. O., Fatoki, O. A., & Akanni, O. F. (2020). Farmers’ knowledge and attitude towards the adoption of agroforestry practices in Akinyele Local Government Area, Ibadan, Nigeria. Journal of Applied Sciences and Environmental Management, 24(10), 1775–1780.
    Citations: 31

  3. Ibrahim, A., Abdullah, R., Ismail, W. N. A. T., & Olaitan, A. (2023). Strategy formulation to empower indigenous community involvement in cultural ecological tourism of Kuala Tahan National Park. Planning Malaysia, 21, 36–47.
    Citations: 19

  4. Ibrahim, A., Olaitan, A. A., Jazmina, W. N., Simin, M. H. A., & Nizam, M. S. (2023). Capacity building of indigenous youth through skills and career training programs in Malaysia. ISVS e-journal, 10(6), 151–163.
    Citations: 13

  5. Rose, A. O., Morenike, T. A., Ahmad, A. O., & Anne, T. F. A. (2020). Predictor of research productivity among married female research scientists in Oyo State, Nigeria. Journal of Finance and Economics, 8(5), 232–236.
    Citations: 9

Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

Posted on by Infectious

Dr. Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

MD | Tehran University of Medical Sciences | Iran

Dr. Shayan Zamani is a dedicated Clinical Research Fellow at the Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, where he has established a strong foundation in dermatology, oncology, and hematopoietic stem cell transplantation. He earned his Doctor of Medicine (MD) with a focus on dermatologic research and clinical therapeutics, combining his medical expertise with evidence-based research in complex dermatological and oncologic disorders. Throughout his career, Dr. Zamani has contributed to multidisciplinary research collaborations exploring topics such as graft-versus-host disease (GVHD), drug-resistant fungal infections, cutaneous complications in oncology patients, and innovative nanoliposomal treatments for fungal and inflammatory skin diseases. His professional experience spans both clinical and laboratory environments, where he integrates translational methodologies to improve diagnostic precision and patient outcomes. His research interests center on dermatologic oncology, infectious skin diseases, immunodermatology, and regenerative therapies, supported by his skills in clinical trial design, biomarker analysis, molecular diagnostics, and data-driven evaluation of treatment efficacy. Dr. Zamani has authored several peer-reviewed publications in reputable journals such as JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Frontiers in Oncology, and Dermatologic Therapy, contributing valuable insights into skin disease pathophysiology and treatment optimization. His work has earned him recognition for academic excellence and commitment to advancing medical science. Dr. Zamani has actively participated in research collaborations and conferences, reflecting strong leadership and dedication to clinical innovation. With a growing publication record and a clear focus on improving therapeutic outcomes, he continues to strengthen his role in advancing dermatologic and oncologic research globally. His academic impact is demonstrated by 19 citations , 11 publications, and an h-index of 3.

Profiles : Google Scholar | Scopus | ORCID

Featured Publications

1. Tamimi, P., Fattahi, M., Ghaderi, A., Firooz, A., Shirvani, F., Alkhen, A., & Zamani, S. (2024). Terbinafin‐resistente Trichophyton indotineae mit F397L/L393S‐ oder F397L/L393F‐Mutation bei Patienten mit Tinea incognita unter Glukokortikosteroiden. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(7), 922–935.

2. Samadi, A., Ayatollahi, A., Kashani, M. N., Zamani, S., & Firooz, A. (2023). Efficacy and tolerability assessment of a polynucleotide‐based gel for improvement of pattern hair loss: A polynucleotide‐based gel for improvement of pattern hair loss. [Journal name not specified].

3. Mehdizadeh, M., Tehrani, H. A., Rezvani, H., Zamani, S., Salari, S., & Hajifathali, A. (2023). Maintenance therapy with Everolimus in patients with refractory or relapsing Hodgkin lymphoma after autologous stem cell transplantation. Blood Cell Therapy, 6(3), 87–93.

4. Zamani, S., Azhdari, H., & Mehdizadeh, M. (2023). Efficacy and safety profile of Everolimus as a maintenance therapy for primary refractory/relapsing Hodgkin lymphoma following autologous hematopoietic stem cell transplantation. HemaSphere, 7(S3), e9236902.

5. Zamani, S., Mehdizadeh, M., & Salem, A. (2023). Allogeneic stem cell transplantation outcomes in Hodgkin lymphoma: A prognostic study of 30 patients with relapsed and refractory Hodgkin lymphoma. HemaSphere, 7(S3), e621289b.

 

JungWoo Shin | Microbial Pathogenesis and Virulence | Best Researcher Award

Posted on by Infectious

Mr. JungWoo Shin | Microbial Pathogenesis and Virulence | Best Researcher Award

Master’s degree | KyungHee University | South Korea

Prof. Jungwoo Shin is a distinguished scholar and researcher at Kyung Hee University, Seoul, South Korea, recognized for his pioneering contributions in the fields of consumer behavior, technology adoption, behavioral economics, and human–computer interaction. He earned his Ph.D. in Economics and Management, where he developed expertise at the intersection of technological innovation and social science, focusing on how individuals and societies adapt to emerging digital ecosystems. Throughout his academic career, Prof. Shin has held several key academic and research positions, demonstrating exceptional leadership in both teaching and multidisciplinary research. His professional experience includes collaborations across international institutions and participation in cutting-edge studies on artificial intelligence interfaces, digital marketing strategies, and sustainable technology systems. Prof. Shin’s research interests span digital transformation, AI-driven user experience, sustainable economic systems, and social media engagement, integrating empirical modeling and behavioral analytics to address modern societal challenges. His research skills encompass quantitative analysis, conjoint experiments, econometric modeling, and data-driven decision-making frameworks, which have been effectively applied in numerous high-impact studies published in top-ranked journals such as Computers in Human Behavior, Applied Economics, International Journal of Human–Computer Interaction, and Technology in Society. Over the years, Prof. Shin has received academic honors and recognition for his outstanding publications and contributions to technology and behavioral sciences, further establishing his reputation as a thought leader in his domain. Dedicated to mentoring students and fostering global collaboration, he continues to influence the academic and research community with innovative insights and a commitment to advancing digital human interaction research. His scholarly impact is further underscored by 2,416 citations  , 93 publications, and an h-index of 26.

Profiles : Google Scholar | Scopus | ORCID

Featured Publications

1. Park, S. Y., Park, C., Seo, J., & Shin, J. (2025). Public willingness to pay for chemical regulation in South Korea: The case of restriction on arsenic use. Environment, Development and Sustainability, 27(5), 11509–11526.
Citations: 2

2. Oh, M., Moon, H. B., Woo, J. R., Kim, H., & Shin, J. (2024). How to be a winner of future vehicle maintenance services: Consumer preference for vehicle self-diagnosis and fault prediction system in next-generation vehicles. Technology Analysis & Strategic Management, 1–13.
Citations: 2

3. Hong, Y., Shin, J., Choi, H., & Ahn, J. W. (2024). Investigating the value of parallel pipeline projects for water supply: A contingent valuation study in South Korea. Water, 16(6), 819.
Citations: 2

4. Kim, K., Shin, J., & Choi, J. Y. (2017). Impact analysis of economic contributors on knowledge creation activity by using the symmetric decomposition method. Symmetry, 9(11), 251.
Citations: 2

5. Kang, C., Lee, C., Zhao, X., Lee, D., Shin, J., & Lee, J. (2025). Safety still matters: Unveiling the value propositions of augmented reality head-up displays in autonomous vehicles through conjoint analysis. Travel Behaviour and Society, 39, 100915.
Citations: 1

Salauddin Al Azad | Infectious Diseases Prevention | Best Researcher Award

Posted on by Infectious

Dr. Salauddin Al Azad | Infectious Diseases Prevention | Best Researcher Award

Principal Investigator | Jiangnan University | China

Dr. Salauddin Al Azad is an accomplished researcher and CSC Scholar at the Key Laboratory of Industrial Biotechnology, Jiangnan University, China, and Principal Investigator of the RPG Interface Lab, Bangladesh. His research primarily focuses on synthetic biology, molecular engineering, and biorefinery processes for sustainable bioenergy production. He has made significant contributions to microbial lipid-based biorefineries, lignocellulosic biomass fractionation, molecular docking, and computational biochemistry. His expertise spans wet-lab techniques such as enzymatic hydrolysis, gene sequencing, and nanoencapsulation, as well as dry-lab and in silico methods including molecular dynamics simulation, density functional theory, and machine learning-driven bioprocess optimization. Salauddin’s multidisciplinary research integrates biochemistry, nanobiocomposite design, and immunoinformatics to develop advanced strategies for biofuel production, drug delivery, and enzyme stabilization. With 33 publications, including 20 indexed in SCI journals and 12 in Q1, his scientific contributions have gained substantial recognition, achieving 856 citations, an h-index of 19, and an i10-index of 25. His recent works in high-impact journals such as Biofuel Research Journal, Fuel, ACS Sustainable Chemistry & Engineering, and Bioresource Technology highlight innovations in green chemistry, computational modeling, and sustainable energy technologies. He has collaborated extensively with global research institutions and contributed as a reviewer and editorial board member for reputed publishers, reflecting his academic influence. Salauddin’s projects have been supported by the National Natural Science Foundation of China, the World Bank, and the Bangladesh Academy of Science, among others. His dedication to advancing molecular biotechnology, bioenergy, and material science has positioned him among the top global researchers in fields like biopolymer engineering, nanobiocomposites, and functional lipids. 492 Citations, 20 Documents, 13 h-index, View h-index.

Profiles :  Google Scholar | Scopus | ORCID

Featured Publications

Al Azad, S., Madadi, M., Saleknezhad, M., Zhang, E., & Sun, F. (2025). Machine learning-driven optimization of biphasic pretreatment conditions for enhanced lignocellulosic biomass fractionation. Energy, 136241. Cited by 8

Al Azad, S., Madadi, M., Rahman, A., Sun, C., Zhang, E., & Sun, F. (2025). Quantum mechanical insights into lignocellulosic biomass fractionation through an NaOH-catalyzed Triton-X 100 system: In vitro and in silico approaches. ACS Sustainable Chemistry & Engineering, 13(15), 5516–5530. Cited by 3